The future of personalized cancer treatment is on its way

BC Cancer Agency will launch innovative immunotherapy clinical trials beginning in 2017

Sponsored by BC Cancer Foundation | Impress Branded Content

After more than a decade of laboratory research, a revolutionary approach to cancer treatment is set to launch in British Columbia with clinical trials beginning early in the new year.

Dr. Brad Nelson, director of the BC Cancer Agency’s Deeley Research Centre in Victoria, and his colleagues are joining forces with experts at the BC Cancer Agency’s Genome Sciences Centre in Vancouver to deliver truly personalized immunotherapy to patients across the province.

Immunotherapy uses the body’s immune system to help combat cancer. T cells are the immune cells that circulate through the body searching for diseased cells to eliminate. In this case, the concept is to collect, activate, and expand a patient’s own cancer-fighting T cells and infuse large numbers of them back into the patient’s bloodstream.

Once in circulation, the T cells are expected to recognize and destroy cancer cells throughout the body, thereby “super charging” the patient’s immune response to their cancer.

The Deeley Research Centre is just one of three labs in Canada focusing on T cell immunotherapy, and is globally recognized for its work on ovarian cancer.

Thanks to the generous support of BC Cancer Foundation donors, the state-of-the-art Conconi Family Immunotherapy Lab at the BC Cancer Agency’s Deeley Research Centre will allow the research team to grow large numbers of potent, high quality T cells for re-infusion in patients participating in the upcoming clinical trials.

“T cell therapy is the most exciting development I have seen in my career, and research in this area has produced fantastic results,” says Dr. Nelson.

“Initial trials will focus on cervical, endometrial and ovarian cancer. With further support, we hope to extend our work to blood cancers, where genetic engineering will be used to give the T cells an extra boost in their power and precision.”

To help support the next round of trials for leukemia and lymphoma on Vancouver Island, please contact: Alyssa Grace, senior director, development – 250.519.5554 or 1.866.519.5550, or alyssa.grace@bccancer.bc.ca

To learn more about immunotherapy, please visit: bccancerfoundation.com/immunotherapy

Just Posted

Council approved rezoning for Eddy at the Bridge development

Public hearing on Dec. 3 saw host of speakers both for and against the commercial development

What can $4 million get you in real estate in Chilliwack vs. other places in B.C.?

A 78-acre property with a large house – or you could get a condo in Vancouver or an estate mansion in 100 Mile House

Widespread concerns spur UFV to halt international enrolment growth

New target hopes to limit international students to 20% of all enrolment to give time to ‘catch up’

LETTER: Public safety ‘first and foremost consideration,’ says parole board

Board responding to article about Chilliwack halfway house

Lights Tour 2019 takes everyone on a sparkly ride across Chilliwack

The annual list of addresses compiled by CADREB for the 2019 Tour of Homes is almost ready

VIDEO: Boys help rescue Cariboo bear cub

The cub, weighing just 24lbs, has been taken to wildlife sanctuary in Northwest B.C. for the winter

Owners of hotels on Vancouver’s Downtown Eastside fight $1 expropriation in court

Vancouver City Council voted to expropriate the properties for $1 each in November

‘Things haven’t changed enough:’ Ecole Polytechnique anniversary prompts reflection

Fourteen women were fatally shot by a gunman at the Montreal school on Dec. 6, 1989

Bear raids freezer, gorges on Island family’s Christmas baking

Hungry bruin virtually ignored meat and fish, focused, instead, on the sweets

B.C. pharmaceutical company’s stocks double in value after successful lupus drug trial

More than 40 per cent of patients using voclosporin saw improvements in kidney function

Second warning on romaine lettuce from California region as another E. coli case reported

Two cases of E. coli have been reported in relation to the illness in the U.S.

Braille signs coming to TransLink bus stops in 2020

Transit authority says it’s the first to do so in Canada and the United States

CUPE issues 72-hour strike notice for SkyTrain

Local 7000 release states ‘parties are still bargaining’, union will have job action plan by Saturday

Abbotsford man was ‘unintended victim’ of 2018 fatal shooting, police say

Jagvir Malhi, 19, was gunned down while on his way to university

Most Read